The slip
PARKINSON RECEIPTno. 15391
30 Oct 2026, 18:37 UTColigodendrocytes, braak
predictionARHGEF10 in oligodendrocytes tracks Braak Lewy-body stage
registered449a72775815d449
discovery+0.08 p=0.833 n=9
replication+0.12 p=0.749 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.08, p 0.833)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT24882265065cef5f6ed3ef0d…
follows 5cdfd4984412…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 15391: ARHGEF10 in oligodendrocytes, braak
- power
- full sample -0.00 (p 0.997, n 18), 95% CI -0.47 to +0.47. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.03 (p 0.915, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.04 (p 0.888, n 18). could be the mix.
- skeptic
- leave-one-out range -0.15 to +0.14, sign flips 8; without severely affected donors -0.00 (p 0.997, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ARHGEF10 in oligodendrocytes.
case closed: nothing better to follow up.